Healthpeak Lifts 2026 FFO Forecast To $1.76-$1.78 A Share As Janus Living Revenue Jumps 78%

The healthcare landlord raised its operating profit outlook even as third-quarter FFO as Adjusted slipped to $0.44 a share from $0.46.

Share
Healthpeak Lifts 2026 FFO Forecast To $1.76-$1.78 A Share As Janus Living Revenue Jumps 78%

Healthpeak Properties, the Denver-based real estate investment trust that owns outpatient medical, lab and senior housing buildings, raised its 2026 outlook for diluted FFO as Adjusted — its key operating profit measure — to $1.76-$1.78 a share, from $1.73-$1.77, in results issued Monday. The lift came even though third-quarter FFO as Adjusted slipped to $0.44 a share from $0.46 a year earlier.

Outlook up, earnings guidance down

Healthpeak also raised its same-store cash net operating income growth guidance to 0.5%-2.0% from 0%-1.5%. Net income was $0.02 a share in the third quarter, against a loss of $0.17 a year earlier.

Full-year diluted earnings per share guidance moved the other way, to $0.39-$0.41 from $0.48-$0.52. The company attributed the cut mainly to depreciation and amortization on senior housing acquisitions that Janus Living closed in the third quarter and through October 30. Those charges are excluded from FFO as Adjusted, so the change has no effect on that forecast, the company said.

Janus Living drives the growth

Janus Living, the senior housing REIT that Healthpeak owns 69% of, reported third-quarter revenue of $268 million, up 78%. Adjusted EBITDAre, a cash earnings measure, rose 101% to $105 million, and same-store adjusted NOI grew 25.9%.

Janus Living closed $1.75 billion of senior housing acquisitions in the quarter: $1.0 billion through August 3 and a further $743 million after that. It completed about $370 million more from quarter end through October 30, and had roughly $1.2 billion of liquidity.

Elsewhere in the portfolio, outpatient medical same-store adjusted NOI rose 3.1% and lab slipped 0.7%. Total same-store growth was 3.6%. Lab occupancy rose 130 basis points (1.3 percentage points) from the prior quarter.

Lab buys, a new term loan and the call

Healthpeak has bought or is under contract to buy four life science buildings of about 510,000 square feet for roughly $233 million. In October it bought a Houston medical training facility, leased entirely to HCA Healthcare affiliates, for $38 million.

It also signed a $500 million unsecured delayed-draw term loan at SOFR plus 80 basis points, undrawn at closing. Net debt to adjusted EBITDAre was 4.7 times, and liquidity stood at $3.8 billion as of October 30.

Healthpeak holds its earnings call and webcast Tuesday at 10:00 a.m. Eastern.

The monthly dividend stays at $0.10167 a share, an annualized $1.22, with the next record date November 13.

Sources